COMPASS Pathways plc
- Last sale
- Nov 12, 2026 · -1.99%
- Market cap
- $1.29B
- 141.71M shares
- Filings
- 344
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2024derivedN/M FY24 yoy
Q3 2026N/M FY25 yoy
Q3 2026−9.4% FY25 yoy
- $1.29B
- —
- —
- 9.1×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $118,436,000 | reported | |
| FY 2024 | 2024-12-31 | $119,039,000 | reported | |
| FY 2023 | 2023-12-31 | $87,518,000 | reported | |
| FY 2022 | 2022-12-31 | $65,053,000 | reported | |
| FY 2021 | 2021-12-31 | $44,027,000 | reported | |
| FY 2020 | 2020-12-31 | $23,366,000 | reported | |
| FY 2019 | 2019-12-31 | $12,563,000 | reported |
Pharmaceutical preparations
COMPASS Pathways plc is the 132nd largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
INVAInnoviva, Inc.$411.3M14.7%65.9%$1.3BOMEROmeros Corp———$1.3BMNKDMannkind Corp$349.0M22.2%1.7%$1.3BKARDKardigan, Inc.———$1.3BURGNUroGen Pharma Ltd.$109.8M21.4%139.8%$1.3B
CMPSCOMPASS Pathways plc (this company)———$1.3B
NKTRNektar Therapeutics$55.2M43.9%297.1%$1.3BSNDXSyndax Pharmaceuticals Inc$172.4M627.8%165.6%$1.3BLBRXLB Pharmaceuticals Inc———$1.3BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
COMPASS Pathways plc · CIK 1816590 · Engraved from SEC EDGAR